| Primary |
| Contraception |
51.2% |
| Post Coital Contraception |
43.5% |
| Depression |
0.8% |
| Premenstrual Syndrome |
0.8% |
| Contraceptive Device Complication |
0.4% |
| Emergency Care |
0.4% |
| Hypothyroidism |
0.4% |
| Oral Contraception |
0.4% |
| Pregnancy On Contraceptive |
0.4% |
| Restless Legs Syndrome |
0.4% |
| Seasonal Allergy |
0.4% |
| Supplementation Therapy |
0.4% |
| Urinary Tract Infection |
0.4% |
| Weight Decreased |
0.4% |
|
| Vaginal Haemorrhage |
13.2% |
| Menstruation Irregular |
10.5% |
| Pregnancy After Post Coital Contraception |
10.5% |
| Unintended Pregnancy |
10.5% |
| Uterine Haemorrhage |
8.4% |
| Vomiting |
7.4% |
| Metrorrhagia |
4.7% |
| Nausea |
4.7% |
| Haematemesis |
3.7% |
| Syncope |
3.7% |
| Ectopic Pregnancy |
3.2% |
| Pelvic Pain |
3.2% |
| Premature Baby |
3.2% |
| Thrombosis |
2.6% |
| Loss Of Consciousness |
2.1% |
| Pancreatitis |
2.1% |
| Drug Exposure During Pregnancy |
1.6% |
| Pulmonary Embolism |
1.6% |
| Pyrexia |
1.6% |
| Vaginal Discharge |
1.6% |
|
| Secondary |
| Contraception |
42.1% |
| Product Used For Unknown Indication |
15.8% |
| Post Coital Contraception |
14.0% |
| Drug Use For Unknown Indication |
7.0% |
| Oral Contraception |
5.3% |
| Influenza |
3.5% |
| Anxiety |
2.6% |
| Acne |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Drug Dependence |
1.8% |
| Vaginal Mucosal Blistering |
1.8% |
| Hypertension |
0.9% |
| Insomnia |
0.9% |
| Weight Loss Diet |
0.9% |
|
| Vaginal Haemorrhage |
14.9% |
| Menstruation Delayed |
10.6% |
| Urinary Tract Infection |
10.6% |
| Nausea |
8.5% |
| Unintended Pregnancy |
8.5% |
| Vomiting |
8.5% |
| Metrorrhagia |
6.4% |
| Fatigue |
4.3% |
| Unevaluable Event |
4.3% |
| Abdominal Pain |
2.1% |
| Abortion Spontaneous |
2.1% |
| Amenorrhoea |
2.1% |
| Drug Exposure During Pregnancy |
2.1% |
| Drug Ineffective |
2.1% |
| Maternal Exposure Before Pregnancy |
2.1% |
| Maternal Exposure During Pregnancy |
2.1% |
| Menstrual Disorder |
2.1% |
| Menstruation Irregular |
2.1% |
| Pelvic Pain |
2.1% |
| Pyrexia |
2.1% |
|
| Concomitant |
| Contraception |
35.5% |
| Acne |
19.9% |
| Post Coital Contraception |
9.6% |
| Product Used For Unknown Indication |
5.6% |
| Pain |
4.4% |
| Oral Contraception |
4.0% |
| Urticaria |
3.2% |
| Drug Use For Unknown Indication |
2.4% |
| Antibiotic Therapy |
2.0% |
| Premenstrual Syndrome |
2.0% |
| Asthma |
1.6% |
| Hypersensitivity |
1.6% |
| Depression |
1.2% |
| Insomnia |
1.2% |
| Menstruation Irregular |
1.2% |
| Prophylaxis |
1.2% |
| Skin Disorder |
1.2% |
| Antifungal Treatment |
0.8% |
| Dyspepsia |
0.8% |
| Dyspnoea |
0.8% |
|
| Amenorrhoea |
23.3% |
| Pain |
10.5% |
| Pulmonary Embolism |
7.0% |
| Cholecystitis |
5.8% |
| Cholelithiasis |
4.7% |
| Drug Exposure During Pregnancy |
4.7% |
| Gallbladder Disorder |
4.7% |
| Pregnancy On Oral Contraceptive |
4.7% |
| Unintended Pregnancy |
4.7% |
| Vomiting |
4.7% |
| No Adverse Event |
3.5% |
| Vaginal Haemorrhage |
3.5% |
| Anger |
2.3% |
| Anxiety |
2.3% |
| Cerebrovascular Accident |
2.3% |
| Cholecystitis Chronic |
2.3% |
| Hyperhidrosis |
2.3% |
| Metrorrhagia |
2.3% |
| Pain In Extremity |
2.3% |
| Pharyngitis Streptococcal |
2.3% |
|
